A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Public ClinicalTrials.gov record NCT00377234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This 2 arm crossover study will evaluate patient reported preference for either once monthly Boniva (150mg p.o.) or once weekly risedronate (35mg p.o.). Patients with post-menopausal osteoporosis will be randomized to receive Boniva for 3 calendar months or risedronate for 12 weeks; they will then cross over to receive the alternative treatment for a further 12 weeks/3 months. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.
Study identification
- NCT ID
- NCT00377234
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 356 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2006 (Type not available)
- Primary completion
- Aug 2008 (Actual)
- Completion
- Aug 2008 (Actual)
- Last update posted
- Aug 1, 2016
2006 – 2008
United States locations
- U.S. sites
- 48
- U.S. states
- 21
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294-3708 | — |
| Not listed | Mesa | Arizona | 85213 | — |
| Not listed | Scottsdale | Arizona | 85251 | — |
| Not listed | Jonesboro | Arkansas | 72401 | — |
| Not listed | Anaheim | California | 92801 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | Waterbury | Connecticut | 06708 | — |
| Not listed | Boynton Beach | Florida | 33437 | — |
| Not listed | Jupiter | Florida | 33458 | — |
| Not listed | Largo | Florida | 33777 | — |
| Not listed | Leesburg | Florida | 34748 | — |
| Not listed | Merritt Island | Florida | 32952 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Pembroke Pines | Florida | 33024 | — |
| Not listed | Spring Hill | Florida | 34667 | — |
| Not listed | St. Petersburg | Florida | 33606 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | Douglasville | Georgia | 30134 | — |
| Not listed | Gainesville | Georgia | 30501 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Madisonville | Kentucky | 42431 | — |
| Not listed | Bethesda | Maryland | 20817 | — |
| Not listed | Missoula | Montana | 59801 | — |
| Not listed | Omaha | Nebraska | 68134 | — |
| Not listed | Morehead City | North Carolina | 28557 | — |
| Not listed | New Bern | North Carolina | 28562 | — |
| Not listed | Jamestown | North Dakota | 58401 | — |
| Not listed | Cincinnati | Ohio | 45224 | — |
| Not listed | Cincinnati | Ohio | 45236 | — |
| Not listed | Mogadore | Ohio | 44260 | — |
| Not listed | Tulsa | Oklahoma | 74104 | — |
| Not listed | Duncansville | Pennsylvania | 16635 | — |
| Not listed | Erie | Pennsylvania | 16506 | — |
| Not listed | Feasterville | Pennsylvania | 19053 | — |
| Not listed | Philadelphia | Pennsylvania | 19114 | — |
| Not listed | Anderson | South Carolina | 29621 | — |
| Not listed | Memphis | Tennessee | 38120 | — |
| Not listed | Selmer | Tennessee | 38375 | — |
| Not listed | Bedford | Texas | 76021 | — |
| Not listed | Bryan | Texas | 77802 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77024 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Temple | Texas | 76502 | — |
| Not listed | Richmond | Virginia | 23235 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00377234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2016 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00377234 live on ClinicalTrials.gov.